524 related articles for article (PubMed ID: 29453417)
41. Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service.
Westra D; Schouten MI; Stunnenberg BC; Kusters B; Saris CGJ; Erasmus CE; van Engelen BG; Bulk S; Verschuuren-Bemelmans CC; Gerkes EH; de Geus C; van der Zwaag PA; Chan S; Chung B; Barge-Schaapveld DQCM; Kriek M; Sznajer Y; van Spaendonck-Zwarts K; van der Kooi AJ; Krause A; Schönewolf-Greulich B; de Die-Smulders C; Sallevelt SCEH; Krapels IPC; Rasmussen M; Maystadt I; Kievit AJA; Witting N; Pennings M; Meijer R; Gillissen C; Kamsteeg EJ; Voermans NC
J Neuromuscul Dis; 2019; 6(2):241-258. PubMed ID: 31127727
[TBL] [Abstract][Full Text] [Related]
42. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
Mørup SB; Nazaryan-Petersen L; Gabrielaite M; Reekie J; Marquart HV; Hartling HJ; Marvig RL; Katzenstein TL; Masmas TN; Lundgren J; Murray DD; Helleberg M; Borgwardt L
Front Immunol; 2022; 13():906328. PubMed ID: 35874679
[TBL] [Abstract][Full Text] [Related]
43. Clinical whole-exome sequencing for the diagnosis of mendelian disorders.
Yang Y; Muzny DM; Reid JG; Bainbridge MN; Willis A; Ward PA; Braxton A; Beuten J; Xia F; Niu Z; Hardison M; Person R; Bekheirnia MR; Leduc MS; Kirby A; Pham P; Scull J; Wang M; Ding Y; Plon SE; Lupski JR; Beaudet AL; Gibbs RA; Eng CM
N Engl J Med; 2013 Oct; 369(16):1502-11. PubMed ID: 24088041
[TBL] [Abstract][Full Text] [Related]
44. Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.
Sawyer SL; Hartley T; Dyment DA; Beaulieu CL; Schwartzentruber J; Smith A; Bedford HM; Bernard G; Bernier FP; Brais B; Bulman DE; Warman Chardon J; Chitayat D; Deladoëy J; Fernandez BA; Frosk P; Geraghty MT; Gerull B; Gibson W; Gow RM; Graham GE; Green JS; Heon E; Horvath G; Innes AM; Jabado N; Kim RH; Koenekoop RK; Khan A; Lehmann OJ; Mendoza-Londono R; Michaud JL; Nikkel SM; Penney LS; Polychronakos C; Richer J; Rouleau GA; Samuels ME; Siu VM; Suchowersky O; Tarnopolsky MA; Yoon G; Zahir FR; ; ; Majewski J; Boycott KM
Clin Genet; 2016 Mar; 89(3):275-84. PubMed ID: 26283276
[TBL] [Abstract][Full Text] [Related]
45. Tiered analysis of whole-exome sequencing for epilepsy diagnosis.
Dunn PJ; Maher BH; Albury CL; Stuart S; Sutherland HG; Maksemous N; Benton MC; Smith RA; Haupt LM; Griffiths LR
Mol Genet Genomics; 2020 May; 295(3):751-763. PubMed ID: 32146541
[TBL] [Abstract][Full Text] [Related]
46. Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy: Outcomes and Lessons Learned.
Ghaoui R; Cooper ST; Lek M; Jones K; Corbett A; Reddel SW; Needham M; Liang C; Waddell LB; Nicholson G; O'Grady G; Kaur S; Ong R; Davis M; Sue CM; Laing NG; North KN; MacArthur DG; Clarke NF
JAMA Neurol; 2015 Dec; 72(12):1424-32. PubMed ID: 26436962
[TBL] [Abstract][Full Text] [Related]
47. Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort.
Nazeha N; Koh AL; Kam S; Lim JY; Goh DLM; Jamuar SS; Graves N
Am J Med Genet A; 2022 Dec; 188(12):3482-3491. PubMed ID: 36156406
[TBL] [Abstract][Full Text] [Related]
48. Whole exome sequencing in a large pedigree with DCM identifies a novel mutation in
Robyns T; Willems R; Van Cleemput J; Jhangiani S; Muzny D; Gibbs R; Lupski JR; Breckpot J; Devriendt K; Corveleyn A
Acta Cardiol; 2020 Dec; 75(8):748-753. PubMed ID: 31583969
[No Abstract] [Full Text] [Related]
49. Comparison of medical management and genetic counseling options pre- and post-whole exome sequencing for patients with positive and negative results.
Matias M; Wusik K; Neilson D; Zhang X; Valencia CA; Collins K
J Genet Couns; 2019 Apr; 28(2):182-193. PubMed ID: 30648779
[TBL] [Abstract][Full Text] [Related]
50. Impact of variation in practice in the prenatal reporting of variants of uncertain significance by commercial laboratories: Need for greater adherence to published guidelines.
Cornthwaite M; Turner K; Armstrong L; Boerkoel CF; Chang C; Lehman A; Nikkel SM; Patel MS; Van Allen M; Langlois S
Prenat Diagn; 2022 Nov; 42(12):1514-1524. PubMed ID: 36068917
[TBL] [Abstract][Full Text] [Related]
51. Fundoscopy-directed genetic testing to re-evaluate negative whole exome sequencing results.
Cho A; Lima de Carvalho JR; Tanaka AJ; Jauregui R; Levi SR; Bassuk AG; Mahajan VB; Tsang SH
Orphanet J Rare Dis; 2020 Jan; 15(1):32. PubMed ID: 32000842
[TBL] [Abstract][Full Text] [Related]
52. Genetic spectrum of renal disease for 1001 Chinese children based on a multicenter registration system.
Rao J; Liu X; Mao J; Tang X; Shen Q; Li G; Sun L; Bi Y; Wang X; Qian Y; Wu B; Wang H; Zhou W; Ma D; Zheng B; Shen Y; Chen Z; Luan J; Wang X; Wang M; Dang X; Wang Y; Wu Y; Hou L; Sun S; Li Q; Liu X; Bai H; Yang Y; Shao X; Li Y; Zheng S; Han M; Liu C; Cao G; Zhao L; Qiu S; Dong Y; Zhu Y; Wang F; Zhang D; Li Y; Zhao L; Yang C; Luo X; Chen L; Jiang X; Zhang A; Xu H;
Clin Genet; 2019 Nov; 96(5):402-410. PubMed ID: 31328266
[TBL] [Abstract][Full Text] [Related]
53. Clinical application of whole-exome sequencing across clinical indications.
Retterer K; Juusola J; Cho MT; Vitazka P; Millan F; Gibellini F; Vertino-Bell A; Smaoui N; Neidich J; Monaghan KG; McKnight D; Bai R; Suchy S; Friedman B; Tahiliani J; Pineda-Alvarez D; Richard G; Brandt T; Haverfield E; Chung WK; Bale S
Genet Med; 2016 Jul; 18(7):696-704. PubMed ID: 26633542
[TBL] [Abstract][Full Text] [Related]
54. Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls.
McInerney-Leo AM; Duncan EL
Front Endocrinol (Lausanne); 2020; 11():628946. PubMed ID: 33679611
[TBL] [Abstract][Full Text] [Related]
55. Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases.
Salfati EL; Spencer EG; Topol SE; Muse ED; Rueda M; Lucas JR; Wagner GN; Campman S; Topol EJ; Torkamani A
Genome Med; 2019 Dec; 11(1):83. PubMed ID: 31847883
[TBL] [Abstract][Full Text] [Related]
56. Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients.
Fichna JP; Macias A; Piechota M; Korostyński M; Potulska-Chromik A; Redowicz MJ; Zekanowski C
Hum Genomics; 2018 Jul; 12(1):34. PubMed ID: 29970176
[TBL] [Abstract][Full Text] [Related]
57. Comparison of different genetic testing modalities applied in paediatric patients with steroid-resistant nephrotic syndrome.
Cheng X; Chen J; Yang X; Chan H; Yang X; Jiao J; Wang A; Zhang G; Chen X; Li X; Wang M; Yang B; Yang H; Li Q
Ital J Pediatr; 2024 Apr; 50(1):85. PubMed ID: 38654395
[TBL] [Abstract][Full Text] [Related]
58. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement.
Stark Z; Schofield D; Alam K; Wilson W; Mupfeki N; Macciocca I; Shrestha R; White SM; Gaff C
Genet Med; 2017 Aug; 19(8):867-874. PubMed ID: 28125081
[TBL] [Abstract][Full Text] [Related]
59. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology.
Vissers LELM; van Nimwegen KJM; Schieving JH; Kamsteeg EJ; Kleefstra T; Yntema HG; Pfundt R; van der Wilt GJ; Krabbenborg L; Brunner HG; van der Burg S; Grutters J; Veltman JA; Willemsen MAAP
Genet Med; 2017 Sep; 19(9):1055-1063. PubMed ID: 28333917
[TBL] [Abstract][Full Text] [Related]
60. New perspective in diagnostics of mitochondrial disorders: two years' experience with whole-exome sequencing at a national paediatric centre.
Pronicka E; Piekutowska-Abramczuk D; Ciara E; Trubicka J; Rokicki D; Karkucińska-Więckowska A; Pajdowska M; Jurkiewicz E; Halat P; Kosińska J; Pollak A; Rydzanicz M; Stawinski P; Pronicki M; Krajewska-Walasek M; Płoski R
J Transl Med; 2016 Jun; 14(1):174. PubMed ID: 27290639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
